Tang Xiao-Qing, Liao Xiangmin, Piccirilli Joseph A.
Howard Hughes Medical Institute, Departments of Biochemistry & Molecular Biology and Chemistry, The University of Chicago, 5841 South Maryland Avenue, MC 1028, Chicago, Illinois 60637.
J Org Chem. 1999 Feb 5;64(3):747-754. doi: 10.1021/jo981329u.
We describe a strategy for the incorporation of a 2'-C-branched ribonucleoside, 2'-C-beta-methylcytidine, into oligonucleotides via solid-phase synthesis using phosphoramidite derivatives. 4-N-Benzoyl-2'-C-beta-methylcytidine (2b) was synthesized by coupling persilylated 4-N-benzoylcytosine with 1,2,3,5-tetra-O-benzoyl-2-C-beta-methyl-alpha-(and beta)-D-ribofuranose (1) in the presence of SnCl(4) in acetonitrile, followed by selective deprotection with NaOH in pyridine/methanol. The 3'- and 5'-hydroxyl groups were blocked as a cyclic di-tert-butylsilanediyl ether 3 by treatment with di-tert-butyldichlorosilane/AgNO(3) in DMF. The 2'-hydroxyl group was then protected as a tert-butyldimethylsilyl ether 4a by treatment with tert-butylmagnesium chloride followed by addition of tert-butyldimethylsilyl trifluoromethanesulfonate in THF. As an alternative to 2'-silyl protection, the corresponding 2'-O-tetrahydropyranyl ether 4b was prepared by treatment of 3 with 4,5-dihydro-2H-pyran in the presence of a catalytic amount of 10-camphorsulfonic acid in methylene chloride. The di-tert-butylsilanediyl groups of 4a and 4b were removed by treatment with pyridinium poly(hydrogen fluoride) to afford 5a and 5b, respectively. Protection of the 5'-hydroxyl group as a dimethoxytrityl ether and phosphitylation of the 3'-hydroxyl group by the standard procedure gave the phosphoramidite derivatives 7a and 7b. Both 7a and 7b could be used to incorporate 2'-C-beta-methylcytidine into oligonucleotides efficiently via standard solid-phase synthesis, but the tetrahydropyranyl group of 7b was more readily removed from oligonucleotides than the tert-butyldimethylsilyl group of 7a. Oligonucleotides containing 2'-C-beta-methylcytidine undergo base-catalyzed degradation analogous to natural RNA.
我们描述了一种通过使用亚磷酰胺衍生物进行固相合成,将2'-C-支链核糖核苷2'-C-β-甲基胞苷掺入寡核苷酸的策略。4-N-苯甲酰基-2'-C-β-甲基胞苷(2b)是通过在乙腈中,在SnCl(4)存在下,将全硅烷基化的4-N-苯甲酰基胞嘧啶与1,2,3,5-四-O-苯甲酰基-2-C-β-甲基-α-(和β)-D-核糖呋喃糖(1)偶联,然后在吡啶/甲醇中用NaOH进行选择性脱保护而合成的。通过在DMF中用二叔丁基二氯硅烷/AgNO(3)处理,将3'-和5'-羟基封端为环状二叔丁基硅烷二醚3。然后在THF中用叔丁基氯化镁处理,接着加入叔丁基二甲基甲硅烷基三氟甲磺酸酯,将2'-羟基保护为叔丁基二甲基甲硅烷基醚4a。作为2'-硅烷基保护的替代方法,在二氯甲烷中,在催化量的10-樟脑磺酸存在下,用4,5-二氢-2H-吡喃处理3,制备相应的2'-O-四氢吡喃基醚4b。用聚(氟化氢)吡啶处理4a和4b的二叔丁基硅烷二醚基团,分别得到5a和5b。通过标准程序将5'-羟基保护为二甲氧基三苯甲基醚并将3'-羟基磷酰化,得到亚磷酰胺衍生物7a和7b。7a和7b都可用于通过标准固相合成有效地将2'-C-β-甲基胞苷掺入寡核苷酸中,但7b的四氢吡喃基比7a的叔丁基二甲基甲硅烷基更容易从寡核苷酸中除去。含有2'-C-β-甲基胞苷的寡核苷酸会经历类似于天然RNA的碱催化降解。